Arber Kodra, MD
Interventional Cardiology · New York, NYNPI 1205270279
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (28.3%), food and beverage and grants — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Medtronic at 39.3% of the total. 2025 is the largest year on record at $47,832, 6.9 times the $6,970 reported in 2019. Among interventional cardiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 562 payments — averaging $252.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$56K
- Shockwave Medical, Inc$26K
- Cathworks, Inc.$13K
- Abbott$13K
- Biotronik Inc.$6K
- Boston Scientific$5K
- plus $23K from 33 others
Across 3 payments — averaging $87.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$263
What the payments were for
- Consulting fees$12,1009%
- Speaking & faculty fees$40,19728%
- Grants$32,10523%
- Travel & lodging$24,50617%
- Food & beverage$32,89923%
- Education$2100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 82 | $55,771 |
| Shockwave Medical, Inc | 38 | $25,816 |
| Cathworks, Inc. | 13 | $13,419 |
| Abbott | 79 | $13,363 |
| Biotronik Inc. | 20 | $6,102 |
| Boston Scientific | 57 | $4,806 |
| Edwards Lifesciences | 29 | $4,154 |
| Abiomed | 23 | $3,255 |
| Inari Medical, Inc. | 17 | $1,730 |
| Cardiovascular Systems Inc. | 22 | $1,713 |
| Philips North America LLC | 18 | $1,436 |
| Heartflow, Inc. | 19 | $1,187 |
| Cordis US CORP. | 2 | $1,122 |
| Spectrawave, Inc | 6 | $822 |
| Siemens Medical Solutions USA, Inc. | 6 | $769 |
| Johnson & Johnson | 13 | $651 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 25 | $593 |
| AstraZeneca(2 entities) | 16 | $582 |
| Angiodynamics, Inc. | 8 | $493 |
| Saranas, Inc. | 4 | $437 |
| Acist Medical Systems, Inc. | 7 | $431 |
| Novo Nordisk | 9 | $422 |
| Penumbra, Inc. | 8 | $381 |
| Endologix LLC | 3 | $333 |
| Teleflex LLC | 3 | $316 |
| Amgen | 8 | $268 |
| Pfizer | 6 | $222 |
| Terumo Medical Corporation | 3 | $195 |
| Recor Medical Inc | 2 | $194 |
| Novartis | 4 | $183 |
| Stryker | 1 | $182 |
| Esperion Therapeutics, Inc. | 1 | $150 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Irhythm Technologies, Inc. | 1 | $116 |
| Astellas Pharma US Inc | 2 | $104 |
| Portola Pharmaceuticals, LLC | 3 | $65 |
| Cardiva Medical, Inc. | 1 | $44 |
| W. L. Gore & Associates, Inc. | 1 | $43 |
| ZOLL Medical Corporation | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRangio$32,419
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$25,103
- CoreValve Evolut$22,000
- Impella$2,548
- AMPLATZER AMULET$1,562
- CT THROMBECTOMY SYSTEM KIT$1,369
- FLOWTRIEVER CATHETER, S$1,369
- Resolute$1,292
- PRO-Kinetic Energy$1,247
- AVVIGO Guidance System$1,161
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,131
- GENERAL - STRUCTURAL HEART$1,105
- Diamondback Coronary$931
- BioMonitor$785
- COREVALVE EVOLUT R$746
- HyperVue Imaging System$711
- Starlight Imaging Catheter$711
- FFRct$576
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$435
- Vascular Lithotripsy$398
How this compares
$142,018 in reported general payments places this provider in the 90th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $21,897 |
| Rosuvastatin Calcium | 13 | $378 |
| Metoprolol Succinate | 36 | $333 |
| Atorvastatin Calcium | 59 | $262 |
| ClopidogrelClopidogrel Bisulfate | 65 | $251 |
| Pantoprazole Sodium | 25 | $193 |
| Carvedilol | 23 | $175 |
| Hydralazine Hcl | 13 | $148 |
| Amlodipine Besylate | 29 | $134 |
| Torsemide | 11 | $99 |
| Nifedipine ErNifedipine | 11 | $80 |
| Losartan Potassium | 19 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $222 | $21,89728 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 382 interventional cardiology providers in New York.
Other interventional cardiology in New York
- Sahil ParikhNew York$1.6M
- Deepak BhattNew York$1.6M
- Martin LeonNew York$1.5M
- Sripal BangaloreNew York$482K
- Ajay KirtaneNew York$462K
- Prakash KrishnanNew York$387K
- Jaikirshan KhatriNew York$307K
- Samin SharmaNew York$291K
- Torsten VahlNew York$280K
- George DangasNew York$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.